Literature DB >> 8666948

The beta subunit of human granulocyte-macrophage colony-stimulating factor receptor forms a homodimer and is activated via association with the alpha subunit.

A Muto1, S Watanabe, A Miyajima, T Yokota, K Arai.   

Abstract

Human granulocyte-macrophage colony-stimulating factor (hGM-CSF) receptor (hGMR) consists of alpha and beta subunits, and the precise stoichiometry of these subunits has remained to be determined. In this work, oligomerization of the beta subunit was studied using a chemical cross-linker. In Ba/F3, a mouse interleukin-3-dependent cell line expressing both subunits of hGMR (Ba/F3-alpha,beta), a protein with a molecular mass corresponding to that of a homodimer of the beta subunit (beta homodimer) was detected only when cells were treated with the cross-linker. Dimerization of the beta subunit was confirmed by coimmunoprecipitation of a tagged beta subunit with the wild type beta subunit COS7 cells. The beta homodimer had already formed in the absence of hGM-CSF, whereas stimulation with the ligand brought both alpha and beta subunits into a complex, the result being tyrosine phosphorylation of the beta homodimer. Tyrosine phosphorylation of the subunit was impaired by deletion of the cytoplasmic domain of the alpha subunit without interfering with the association of both subunits. These results indicate that the beta homodimer, which alone is insufficient for signaling, forms the functional hGMR with the alpha subunit in response to hGM-CSF.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8666948      PMCID: PMC2192495          DOI: 10.1084/jem.183.4.1911

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  A point mutation in the neu oncogene mimics ligand induction of receptor aggregation.

Authors:  D B Weiner; J Liu; J A Cohen; W V Williams; M I Greene
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

Review 2.  Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5.

Authors:  A Miyajima; A L Mui; T Ogorochi; K Sakamaki
Journal:  Blood       Date:  1993-10-01       Impact factor: 22.113

3.  Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor.

Authors:  K Hayashida; T Kitamura; D M Gorman; K Arai; T Yokota; A Miyajima
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

Authors:  A M de Vos; M Ultsch; A A Kossiakoff
Journal:  Science       Date:  1992-01-17       Impact factor: 47.728

5.  Monoclonal antibody against the common beta subunit (beta c) of the human interleukin-3 (IL-3), IL-5, and granulocyte-macrophage colony-stimulating factor receptors shows upregulation of beta c by IL-1 and tumor necrosis factor-alpha.

Authors:  Y Watanabe; T Kitamura; K Hayashida; A Miyajima
Journal:  Blood       Date:  1992-11-01       Impact factor: 22.113

6.  Reconstituted human granulocyte-macrophage colony-stimulating factor receptor transduces growth-promoting signals in mouse NIH 3T3 cells: comparison with signalling in BA/F3 pro-B cells.

Authors:  S Watanabe; A L Mui; A Muto; J X Chen; K Hayashida; T Yokota; A Miyajima; K Arai
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

7.  N-hydroxysulfosuccinimide active esters: bis(N-hydroxysulfosuccinimide) esters of two dicarboxylic acids are hydrophilic, membrane-impermeant, protein cross-linkers.

Authors:  J V Staros
Journal:  Biochemistry       Date:  1982-08-17       Impact factor: 3.162

8.  IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase.

Authors:  M Murakami; M Hibi; N Nakagawa; T Nakagawa; K Yasukawa; K Yamanishi; T Taga; T Kishimoto
Journal:  Science       Date:  1993-06-18       Impact factor: 47.728

9.  Critical cytoplasmic domains of the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation.

Authors:  K Sakamaki; I Miyajima; T Kitamura; A Miyajima
Journal:  EMBO J       Date:  1992-10       Impact factor: 11.598

10.  Activating point mutations in the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors suggest the involvement of beta subunit dimerization and cell type-specific molecules in signalling.

Authors:  B J Jenkins; R D'Andrea; T J Gonda
Journal:  EMBO J       Date:  1995-09-01       Impact factor: 11.598

View more
  5 in total

1.  Activation of JAK2-V617F by components of heterodimeric cytokine receptors.

Authors:  Anuradha Pradhan; Que T Lambert; Lori N Griner; Gary W Reuther
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

2.  A chimeric serine/threonine kinase receptor system reveals the potential of multiple type II receptors to cooperate with transforming growth factor-beta type I receptor.

Authors:  M Muramatsu; J Yan; K Eto; T Tomoda; R Yamada; K Arai
Journal:  Mol Biol Cell       Date:  1997-03       Impact factor: 4.138

3.  Upregulation of GM-CSF by TGF-β1 in epithelial mesenchymal transition of human HERS/ERM cells.

Authors:  Joo-Hee Lee; Hyun Nam; Soyoun Um; Juhwan Lee; Gene Lee; Byoung Moo Seo
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-11-21       Impact factor: 2.416

4.  Interleukin-5 receptor subunit oligomerization and rearrangement revealed by fluorescence resonance energy transfer imaging.

Authors:  Meirav Zaks-Zilberman; Adrian E Harrington; Tetsuya Ishino; Irwin M Chaiken
Journal:  J Biol Chem       Date:  2008-03-07       Impact factor: 5.157

5.  GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia.

Authors:  Bijay Parajuli; Yoshifumi Sonobe; Jun Kawanokuchi; Yukiko Doi; Mariko Noda; Hideyuki Takeuchi; Tetsuya Mizuno; Akio Suzumura
Journal:  J Neuroinflammation       Date:  2012-12-13       Impact factor: 8.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.